Keywords: celgene, revimid, orphan, drug, says, fda, corp

Celgene's Revimid an orphan drug, says FDA

Article | 09 October 2001

Print This

Celgene Corp's lead immunomodulatory drug (IMiD) Revimid has beengranted orphan drug designation by the US Food and Drug Administration as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in